期刊文献+

肢端肥大症患者生长激素水平及其与临床资料、生化指标及甲状腺激素水平的关系分析

Growth Hormone Level in Patients with Acromegaly and Its Relationship with Clinical Data, Biochemical Indexes and Thyroid Hormone Levels
下载PDF
导出
摘要 目的:探讨肢端肥大症患者生长激素水平及其与临床资料、生化指标及甲状腺激素水平之间的关系。方法:回顾性分析2012年1月~2016年12月在山西医科大学附属人民医院神经外科就诊65例肢端肥大症患者的一般临床资料、肝肾功能等生化指标及甲状腺功能。结果:肢端肥大症患者生长激素水平与临床资料、肝肾功能无相关性(r = ?0.057~?0.104,P均 >0.05);与总胆固醇(TC)呈正相关(r = 0.279, P 0.05);与TSH呈负相关(r = ?0.402, P 4水平呈正相关(r = 0.332, P FT3、TT3、FT4之间无相关性(r = 0.151, ?0.06, 0.243, P >0.05)。结论:肢端肥大症型垂体腺瘤的血清生长激素水平与肿瘤体积、肝功、肾功无相关性。血脂方面,其与TC水平正相关,与LDL、HDL、TG无相关性。甲状腺激素方面,其与TSH水平呈负相关,与TT4水平呈正相关,与FT3、TT3、FT4之间无相关性。 Objective: To explore the growth hormone (GH) level in the patients with acromegaly and its re-lationship with clinical data, biochemical indexes and thyroid hormone levels. Methods: The clinical data, biochemical indicators such as liver and kidney function and thyroid function of 65 acromegaly patients with pituitary adenomas, who visited Shanxi Medical University Affiliated People’s Hospital from January 2012 to December 2016, were analyzed retrospectively. Results: There was no significant correlation among serum GH, clinical data, liver and kidney function in the patients with acromegaly (r = ?0.057 - ?0.104, P >0.05). Serum GH has positive correlation with TC (r = 0.279, P 0.05). Serum GH has negative correlation with TSH (r = ?0.402, P 4 (r = 0.332, P FT3, TT3, FT4 (r = 0.151, ?0.06, 0.243, P >0.05). Conclusions: The serum GH level in the patients with acromegaly is insignificantly related to the adenomas volume, liver function and renal function. In the aspect of blood lipid, , the serum GH level was positively correlated with TC level, and had no correlation with LDL, HDL, TG. In the aspect of thyroid function, the serum GH level was negatively correlated with TSH level and positively correlated with TT4 level, and no correlation with FT3, TT3, FT4.
作者 于鸿悦 胡玲
出处 《临床医学进展》 2017年第1期1-5,共5页 Advances in Clinical Medicine
  • 相关文献

参考文献4

二级参考文献43

  • 1侯曼,刘静民.用生物电阻抗法测量人体体成分及分析[J].中国运动医学杂志,2005,24(1):89-92. 被引量:74
  • 2吴勤勇,朱惠娟,李欣,潘慧,张殿喜,龚凤英,邓洁英,史轶蘩.特发性生长激素缺乏性矮小症在重组人生长激素治疗1年后身体构成的变化[J].中国新药杂志,2006,15(19):1676-1679. 被引量:5
  • 3Katznelson L. Alteration in body composition in acromegaly [J]. Pituitary, 2009, 12(2): 136-42.
  • 4Costa AC, Rossi A, Martinelli CE,et al. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay:Should we achieve strict normal GH levels for a biochemical cure? [ J ]. J Clin Endocri Metab, 2002, 87 (7) :3142-3147.
  • 5O' sullivan AJ,Kelly JJ,Hoffman DM,et al. Body composition and energy expenditure in acromegaly [J]. J Clin Endocri Metab,2006,78 (2) :381 - 386.
  • 6Hansen TB, Gram J, Bjerret P, et al. Body composition in active acromegaly during treatment with octreotide : a doubleblind, placebo-controlled cross-over study [ J ]. Clin Endocri, 1994,41 (3) : 323 - 329.
  • 7Bengtsson BA, Brummer RG,Eden S,et al. Body composition in acromegaly:The effect of treatment [ J ]. Clin Endocri, 1989,31 (4) :481 - 490.
  • 8Colao A,Ferone D,Marzullo P,et al.Systemic complications of acromegaly:epidemiology,pathogenesis,and management.J Endocrine Reviews,2004,25(1):102-152
  • 9Vitale G,Pivonello R,Galderisim,et al.Cardiovarscular complications in acromegaly:methods of assessment.J Pituitary,2001,4(4):251-257
  • 10Cheung NM,Boyages SC.The thyroid gland in acromegaly:an ultrasonographic study.J Clin Endocrinol(Oxf),1997,46(5):545-549

共引文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部